Diane M. Cappelletty

Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections

A Benko, Diane M. Cappelletty, James A. Kruse et al. · Antimicrobial Agents and Chemotherapy · 1996 · 162 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Comparative In Vitro Activities and Postantibiotic Effects of the Oxazolidinone Compounds Eperezolid (PNU-100592) and Linezolid (PNU-100766) versus Vancomycin against <i>Staphylococcus aureus</i> , Coagulase-Negative Staphylococci, <i>Enterococcus faecalis</i> , and <i>Enterococcus faecium</i>

Michael J. Rybak, Diane M. Cappelletty, Tabitha Moldovan et al. · Antimicrobial Agents and Chemotherapy · 1998 · 148 citations · Full text

Medicine, Microbiology, Pharmacology +9

Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa

Diane M. Cappelletty, Michael J. Rybak · Antimicrobial Agents and Chemotherapy · 1996 · 123 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

The Retrospective Cohort of Extended‐Infusion Piperacillin‐Tazobactam (RECEIPT) Study: A Multicenter Study

Raymond Yost, Diane M. Cappelletty · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2011 · 93 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model

Diane M. Cappelletty, Sangrim Kang, Shirley Palmer et al. · Antimicrobial Agents and Chemotherapy · 1995 · 73 citations

Medicine, Pharmacokinetics, Pharmacology +17